Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
The
Dow Jones Industrial Average (
^DJI) is trading down 124.0 points (-0.7%) at 16,959 as of Friday, Jul 25, 2014, 12:36 p.m. ET. During this time, 119.6 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 305.3 million. The NYSE advances/declines ratio sits at 982 issues advancing vs. 1,968 declining with 163 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Holding back the Dow today is
United Technologies (NYSE:
UTX), which is lagging the broader Dow index with a 30-cent decline (-0.3%) bringing the stock to $108.65. This single loss is lowering the Dow Jones Industrial Average by 2.27 points or roughly accounting for 1.8% of the Dow's overall loss. Volume for United Technologies currently sits at two million shares traded vs. an average daily trading volume of 3.3 million shares.
United Technologies has a market cap of $100.59 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are down 4.3% year-to-date as of Thursday's close. The stock's dividend yield sits at 2.1%.
United Technologies Corporation provides technology products and services to the building systems and aerospace industries worldwide.
TheStreet Ratings rates United Technologies as a
buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
